IMOT Intensive Therapy

94% improvement rate is promising; comparison to dose-matched conventional therapy is the key test and evidence is emerging.

Very specialized for children with neurological conditions in intensive therapy settings; limited US availability.

Billed as intensive PT/OT; variable US payer coverage; international origins limit domestic payer recognition.

Specialized intensive program training; limited sites; significant time commitment; international origins.

Limited US employer demand; primarily academic pediatric centers.

Children and families report high satisfaction; peer social environment adds value.

Pediatric intensive model is overwhelmingly cash-pay; parents of children with CP/neuro conditions readily pay.

Burst-care model commands premium block pricing (often $3-8K per intensive).

Distinctive service model that stands out from traditional outpatient peds.

Other trained clinicians can deliver intensives; model scales with staff and facility.

Strong within pediatric neuro parent communities; modest broader awareness.

Moderate training cost; profitable model once operational.

Not a recognized credential for academic promotion.

Limited peer-reviewed literature specific to IMOT branding.

Relevant to peds neuro instruction as a service-delivery model.

Intensive model has some support (HABIT, CIMT literature) but IMOT-specific evidence is thin.

Rarely if ever named in faculty postings.

Short course relative to academic return, but academic return is low.